Michael Block

Pharmacometrics Strategist
Bayer AG, Germany

Poster(s):

• PI-093 - A COMPREHENSIVE MIDD APPROACH TO ASSESS THE SAFETY AND EFFICACY OF TARGETED-THORIUM-CONJUGATES IN PATIENTS FOR EARLY DECISION MAKING.
  Wednesday, March 22, 2023

  5:00 PM – 6:30 PM EDT

• PII-123 - A MODEL-BASED META-ANALYSIS TO ASSESS THE SIMILARITIES AND DIFFERENCES OF CLINICAL SAFETY OF TARGETED-THORIUM-CONJUGATES IN PATIENTS.
  Thursday, March 23, 2023

  5:00 PM – 6:30 PM EDT